Kevin J. Appelbaum - Chief Executive Officer, Director, 10%+ Owner at Better Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director, 10%+ Owner
Stock Symbol
BTTX on Nasdaq
Industry
Services-Health Services
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kevin J. Appelbaum since 7/4/2023

Holdings reported by Kevin J. Appelbaum for Better Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 2,406,719 $409 K $0.17 Mar 31, 2022 By Trust
Common Stock 6,250 $1.06 K $0.17 Mar 31, 2022 Direct
Stock Option (Right to Buy) 235,000 Apr 1, 2022 Direct Common Stock

Transactions reported by Kevin J. Appelbaum for Better Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership